ArticleAntibiotics (Basel, Switzerland)2022

Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry.

Tommaso Lupia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.